Bioporto A/S
CSE:BIOPOR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Bioporto A/S
CSE:BIOPOR
|
DK |
|
B
|
Broadex Technologies Co Ltd
SZSE:300548
|
CN |
|
Fenerbahce Futbol AS
IST:FENER.E
|
TR |
|
HELMA Eigenheimbau AG
XETRA:H5E
|
DE |
|
L'Occitane International SA
F:COC
|
LU |
|
I
|
iPeople Inc
XPHS:IPO
|
PH |
|
Lindsay Australia Ltd
ASX:LAU
|
AU |
|
H
|
HLE Glascoat Ltd
NSE:HLEGLAS
|
IN |
|
B
|
Brimag Digital Age Ltd
TASE:BRMG
|
IL |
|
F
|
Federal International Holdings Bhd
KLSE:FIHB
|
MY |
|
Lotus Bakeries NV
XBRU:LOTB
|
BE |
|
Tan Chong International Ltd
HKEX:693
|
HK |
|
M
|
Marimekko Oyj
OMXH:MEKKO
|
FI |
|
Tower Ltd
NZX:TWR
|
NZ |
|
NextDecade Corp
NASDAQ:NEXT
|
US |
|
Rain Industries Ltd
BSE:500339
|
IN |
|
P
|
Pos Malaysia Bhd
KLSE:LIONPSIM
|
MY |
|
P
|
Pinnacle Food Group Ltd
NASDAQ:PFAI
|
CA |
|
I
|
ISMT Ltd
NSE:ISMTLTD
|
IN |
|
M
|
Masisa SA
SGO:MASISA
|
CL |
|
Can2 Termik AS
IST:CANTE.E
|
TR |
|
Mears Group PLC
LSE:MER
|
UK |
|
Nisso Corp
TSE:6569
|
JP |
Bankruptcy Probability
Bioporto A/S's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Bioporto A/S Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DK |
|
Bioporto A/S
CSE:BIOPOR
|
383.7m DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
374.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
175.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
41B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
68.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Bioporto A/S's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Bioporto A/S has total debt of 4.9m DKK. This includes both short-term (0 DKK) and long-term (4.9m DKK) debt.
You can find a full breakdown on its Balance Sheet.
